Skip to main content

Continuous renal replacement therapy with the adsorbent membrane oXiris in septic patients: a clinical experience

Introduction

Renal failure is an important complication of sepsis and CRRT with adsorbing membranes may be useful in this clinical setting [1]. The aims of the study in septic/septic shock patients are to evaluate: the safety of a new hemofilter membrane oXiris with adsorbing properties and anti-endotoxin activity; the renal and hemodynamic response; and the changes of endotoxin and proinflammatory molecules.

Methods

Forty septic/septic shock patients with renal failure were enrolled in the study. All patients had preoperative endotoxin >0.6 level/units (EAA Spectral D) and were submitted to high-volume hemodiafiltration (50 ml/kg/hour, Prismaflex; Gambro) with a new treated heparin-coated membrane (oXiris; Gambro). At T0 (pre-treatment) and T1 (24 hours) the main clinical and biochemical data were evaluated. All data are expressed as mean ± SD. One-way ANOVA test with Bonferroni correction was used to evaluate the data changes. P < 0.05 was considered significant.

Results

Table 1 presents the main results of this study.

Table 1 (abstract P63)

Conclusion

In septic/septic shock patients with renal failure, CRRT with a new treated heparin-coated membrane (oXiris; Gambro) is clinically feasible, and has a positive effect on renal function and hemodynamics. An adsorbing effect on proinflammatory mediators may have a role in these results. These data and the trend toward a decrease of endotoxin during the treatment warrant further investigation.

References

  1. 1.

    Rimmelé T, et al.: Nephrol Dial Transplant. 2009, 24: 421-427.

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to F Turani.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Turani, F., Candidi, F., Barchetta, R. et al. Continuous renal replacement therapy with the adsorbent membrane oXiris in septic patients: a clinical experience. Crit Care 17, P63 (2013). https://doi.org/10.1186/cc12001

Download citation

Keywords

  • Renal Failure
  • Replacement Therapy
  • Bonferroni Correction
  • Renal Replacement Therapy
  • ANOVA Test